iShares iBonds Dec 2025 Term $ Treasury UCITS ETF (IT25)
Summary
IT25 Chart
iShares iBonds Dec 2025 Term $ Treasury UCITS ETF (IT25) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has iShares iBonds Dec 2025 Term $ Treasury UCITS ETF ever had a stock split?
iShares iBonds Dec 2025 Term $ Treasury UCITS ETF Profile
| LSE Exchange | CA Country |
Overview
RIV Capital Inc., originally recognized as Canopy Rivers Inc., operates as a venture capital firm with a comprehensive and dynamic investment approach primarily targeted towards the burgeoning cannabis industry. The firm, founded in 2017 and headquartered in Toronto, Canada, displays an agnostic stance towards the developmental stages of potential investees, demonstrating a preference for engaging in Series A to C financing rounds. RIV Capital Inc. is dedicated to fostering growth within multiple facets of the cannabis sector, including agriculture, production, pharmaceuticals, software, consumer products, and more, by offering an array of investment strategies ranging from equity to royalty-based financing. With a global outlook for opportunity identification, the firm customarily engages in minority stake investments, offering financial inputs ranging broadly from CA$1 million to CA$40 million, while typically targeting investments between CA$5 million and CA$10 million.
Products and Services
- Cannabis Sector Investments
- Agriculture and Food Sciences
- Production and Processing
- Pharmaceuticals and Biotechnology
- Software, Data, and Hardware
- Consumer Products and Accessories
- Retail and Distribution
- Investment Structures
RIV Capital Inc. spotlights its investment endeavors on the cannabis industry, emphasizing early to mature stages of business development across diverse areas such as agriculture, consumer products, pharmaceuticals, and more.
Investment focus spans across plant science, soil science, food science, and environmental science, aiming to support and elevate innovations in the cultivation and processing of cannabis and related agricultural advancements.
The firm invests in businesses engaged in indoor and outdoor cultivation, greenhouse and nursery cultivation, as well as fermentation. Processing focuses include harvesting, extraction, purification, and food/beverage processing, catering to advancements in productivity and efficiency within the sector.
RIV Capital Inc. contributes to pharmaceutical discovery, development, and the delivery of cannabis-based products. This includes a focus on biosynthetically derived cannabinoids, medical devices, and lab equipment, fostering innovation in medical cannabis applications.
The firm recognizes the importance of technological advancements in cultivation, production, and distribution, investing in software solutions, data analytics, and specialized hardware that facilitate operational efficiencies and market growth.
Investment extends to a variety of consumer-oriented products including edibles, beverages, inhalables, cosmetics, and accessories, aiming to support and expand access to quality cannabis products for adult and medicinal use.
The firm seeks to advance the cannabis retail landscape through investments in brick-and-mortar retailers, pharmacies, online marketplaces, and delivery services, enhancing the accessibility and distribution of cannabis products.
RIV Capital employs a diverse array of investment structures including debt, preferred and common equity, and production-linked royalties, tailored to align with the unique needs and growth stages of investee companies.
